Sabby Management, LLC Oramed Pharmaceuticals Inc. Transaction History

Sabby Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.98 - $29.75 $523,665 - $1.2 Million	-40,344 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $489,372 - $960,994	40,344 New	40,344 $887,000
Q4 2019 Feb 14, 2020	SELL	$2.43 - $5.74 $451,494 - $1.07 Million	-185,800 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$2.88 - $3.96 $486,469 - $668,895	-168,913 Reduced 47.62%	185,800 $593,000
Q2 2019 Aug 14, 2019	SELL	$2.88 - $4.36 $941,146 - $1.42 Million	-326,787 Reduced 47.95%	354,713 $1.27 Million
Q1 2019 May 15, 2019	SELL	$2.95 - $3.64 $742,072 - $915,642	-251,550 Reduced 26.96%	681,500 $2.48 Million
Q4 2018 Feb 14, 2019	BUY	$3.0 - $4.94 $395,424 - $651,131	131,808 Added 16.45%	933,050 $2.8 Million
Q3 2018 Nov 14, 2018	BUY	$4.64 - $7.11 $3.72 Million - $5.7 Million	801,242 New	801,242 $3.88 Million

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.